Epigenetics of Heart Failure, An issue of Heart Failure Clinics
- 1st Edition, Volume 22-1 - November 25, 2025
- Latest edition
- Editor: Ragavendra R. Baliga
- Language: English
In this issue of Heart Failure Clinics, guest editor Dr. Ragavendra R. Baliga brings his considerable expertise to the topic of Epigenetics of Heart Failure. Top experts in th… Read more
Purchase options
Description
Description
In this issue of Heart Failure Clinics, guest editor Dr. Ragavendra R. Baliga brings his considerable expertise to the topic of Epigenetics of Heart Failure. Top experts in the field explore how chemical modifications to DNA and histones influence gene expression without altering the genetic code, contributing to the development and progression of heart failure. Factors such as DNA methylation, histone modifications, and non-coding RNAs can regulate key pathways involved in cardiac remodeling, inflammation, and fibrosis. Environmental influences like diet, stress, and toxins can also impact these epigenetic changes, potentially worsening heart function. Understanding these mechanisms may lead to novel therapeutic targets for preventing or treating heart failure at the molecular level.
Key features
Key features
- Contains 18 relevant, practice-oriented topics including DNA damage response in hereditary cardiomyopathies; novel insights from mammals of extreme longevity into genetic and epigenetic regulation of heart regeneration and repair; epigenetic control in clonal hematopoiesis and impact on heart failure; pharmacological and lifestyle interventions to modulate the epigenome in heart failure; epigenetics in dilated cardiomyopathy; and more
- Provides in-depth clinical reviews on epigenetics of heart failure, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Readership
Readership
Heart Failure Cardiologists
Table of contents
Table of contents
Multiomics Insights into Epigenetic Mechanisms and Their Role as Biomarkers for Acute Coronary Syndrome
Epigenetic Therapeutics in Human Heart Failure
Epigenetic Regulation in Dilated Cardiomyopathy
Pharmacologic and Lifestyle Interventions to Modulate the Epigenome in Heart Failure
The Pathogenic Role of the DNA Double-Stranded Breaks in Hereditary Cardiomyopathies
Genetics of Thoracic and Thoracoabdominal Aortic Dissections and Aneurysms
Genetic Determinants of Response to P2Y 12 Inhibitors and Clinical Implications
Pediatric and Familial Genetic Arrhythmia Syndromes: Evaluation of Bidirectional Ventricular Tachycardia—Differential Diagnosis
Genetic Risk Stratification in Arrhythmogenic Left Ventricular Cardiomyopathy
Emerging Targeted Therapies for Inherited Cardiomyopathies and Arrhythmias
Epigenetic Therapeutics in Human Heart Failure
Epigenetic Regulation in Dilated Cardiomyopathy
Pharmacologic and Lifestyle Interventions to Modulate the Epigenome in Heart Failure
The Pathogenic Role of the DNA Double-Stranded Breaks in Hereditary Cardiomyopathies
Genetics of Thoracic and Thoracoabdominal Aortic Dissections and Aneurysms
Genetic Determinants of Response to P2Y 12 Inhibitors and Clinical Implications
Pediatric and Familial Genetic Arrhythmia Syndromes: Evaluation of Bidirectional Ventricular Tachycardia—Differential Diagnosis
Genetic Risk Stratification in Arrhythmogenic Left Ventricular Cardiomyopathy
Emerging Targeted Therapies for Inherited Cardiomyopathies and Arrhythmias
Product details
Product details
- Edition: 1
- Latest edition
- Volume: 22-1
- Published: November 28, 2025
- Language: English
About the editor
About the editor
RB
Ragavendra R. Baliga
Affiliations and expertise
Inaugural Director, Cardio-Oncology Center of Excellence Professor of Internal Medicine The Ohio State University Wexner Medical Center, USA